Pathogen-Specific Bactericidal Method Mediated by Conjugative Delivery of CRISPR-Cas13a Targeting Bacterial...

Area of Science:

• Microbiology
• Molecular Biology
• Biotechnology

Background:

• Antibiotic resistance poses a significant public health threat.
• Broad-spectrum antibiotics disrupt beneficial gut microbiota, leading to secondary health issues.
• Targeted therapies are needed to eliminate pathogens without harming commensal bacteria.

Purpose of the Study:

• To develop a precise bactericidal system targeting Salmonella Typhimurium.
• To utilize CRISPR-Cas13a technology for specific pathogen elimination.
• To assess the efficacy of conjugation-based delivery for antimicrobial strategies.

Main Methods:

• Designed a CRISPR-Cas13a system targeting endogenous transcripts of Salmonella Typhimurium.
• Delivered the CRISPR-Cas13a system using a conjugative vehicle (Escherichia coli).
• Evaluated the system's efficacy in vitro using mixed microbial flora and in vivo using a mouse infection model.

Main Results:

• The CRISPR-Cas13a system demonstrated specific killing and clearance of Salmonella Typhimurium in vitro.
• In vivo studies showed significant reduction in Salmonella Typhimurium colonization in the mouse intestinal tract.
• Conjugation-based delivery proved feasible and effective for the bactericidal system.

Conclusions:

• The developed CRISPR-Cas13a system offers a precise and effective method for eliminating Salmonella Typhimurium.
• This approach minimizes disruption to the resident gut microbiota, addressing a key limitation of traditional antibiotics.
• The conjugation-based delivery system is adaptable for targeting various pathogens, with potential applications in biotherapy and microbial community modification.